We further demonstrated that miR-195 also targets genes involved in de novo lipogenesis, it inhibits cell proliferation, migration, and invasion by targeting FASN, HMGCR, ACACA and CYP27B1 thereby potentially opening new avenues for the treatment of breast cancer. This evidence concerns the gene HMGCR and breast cancer.